RFA-DA-27-004: BRAIN Initiative Theories, Models and Methods (R01, No Clinical Trials)

RFA-DA-27-004: BRAIN Initiative Theories, Models and Methods (R01, No Clinical Trials)

The NIH BRAIN Initiative continues to fund foundational tools for neuroscience. This funding opportunity (NOFO) supports the development and validation of theories, models and methods (TMM) that can improve quantitative and predictive understanding of brain function across scales. It is aimed at teams that can turn complex model/data work into reusable resources for the neuroscience community.

This is an open, active competition for the 2026–2027 grant cycle with multiple review rounds already listed. The immediate upcoming full submission window for this NOFO is 6 October 2026 (5:00 PM local time of the applicant organization), and the cycle continues with additional rounds in 2027 and 2028. The opportunity remains open for future due dates through November 2027 when the NOFO expires.

Key details at a glance

What this opportunity is and what it is not

This NOFO is not a general neuroscience grant. It is a specific technology-and-methods program under NIH’s BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data. The core ask is to produce theory- and model-based outputs that can interpret multi-scale brain data. The NOFO explicitly prioritizes projects that can build capabilities for analyzing and integrating complex data such as cell-type physiology, connectivity, anatomy, and behavior.

You should treat two parts as strict boundaries:

1. Research scope: The work must be about developing and validating TMM tools with a rigorous mathematical/statistical or computational basis.
2. Clinical scope: Clinical trials are not allowed for this NOFO.

The NOFO also expects deliverables that are shared with the community, not kept proprietary. In practice, that means teams should design outputs that can be adopted, modified, and reused by external researchers.

What tends to be a strong fit:

• Teams with both theoretical and data-rich components, especially those that combine model development with real data testing.
• Projects that can connect neural activity data and behavior, especially when using datasets with cellular or circuit-level temporal resolution.
• Applicants offering concrete user feedback loops with community adopters, not just conceptual modeling papers.

Research focus and in-scope examples

The NOFO describes priority areas around:

• Theories of brain function with quantitative, predictive value.
• Computational models of neural and behavioral dynamics that are interpretable and testable.
• Methods for complex data analysis that can integrate and analyze large neural-behavioral datasets.

To stay compliant, projects should satisfy these practical expectations:

• Theoretical frameworks should be grounded in empirical data.
• Behavioral tools should incorporate neural data and track multiple temporal scales.
• Methods should be built, tested, and evaluated for reproducibility.
• Work should be done as model parameter estimation and validation of the proposed tools.

The NOFO explicitly lists some non-responsive categories, including projects relying only on low-resolution noninvasive data without linkage to cellular/circuit data, and behavior-only tools without neural context or multi-scale framing. If your proposal lacks these elements, even an elegant team may fail at screening before peer review.

A useful practical distinction for applicants:

• Responsive: “How can this model improve predictive neuroscience across data scales and be reusable?”
• Not responsive: “Can we build a tool that does not require high-resolution neural grounding and still call it this NOFO’s target?”

Because this NOFO was reissued under a specific existing framework (RFA-DA-23-039), reviewers expect submissions that connect clearly to BRAIN initiative goals, not standalone theoretical studies detached from this ecosystem.

Eligibility and eligibility caveats in plain language

The opportunity has broad institutional eligibility and appears to include:

• Higher Education Institutions (public/private).
• Nonprofits including but not limited to 501(c)(3)-type structures.
• For-profit organizations and small businesses.
• Local and federal government entities in certain categories.
• Some additional eligible U.S. organizational forms and, under specific conditions, non-domestic entities.

However, there are two caveats that matter:

1) Foreign subawards/subcontracts are heavily restricted

NIH’s policy for this NOFO states that applications with foreign subawards/subcontracts are noncompliant unless the opportunity is explicitly for international collaboration frameworks. In short: if you are planning a U.S.-led project with monetary foreign subawards, this is likely a compliance risk. The NOFO does allow foreign components and foreign consultant-related engagement in non-award forms, but it is strict about funded foreign subcontracting.

So your partner strategy should be:

• Keep foreign participation as unfunded collaboration where possible.
• Verify whether each partner role is compliant with this NOFO’s foreign-subaward rule.
• Ensure your budget aligns with these constraints before submission.

2) Registration requirements are hard gates

The NOFO requires all registrations before submission:

• SAM (including appropriate identifiers, and NCAGE for foreign orgs where needed).
• UEI.
• eRA Commons with a valid signing official and PI profile.
• Grants.gov registration.

The NOFO explicitly flags registration timing as a real blocker. Start at least six weeks ahead because registration issues do not excuse late submission. If your institution has not completed this before the deadline, your application can be rejected at intake.

Deadlines, review rhythm, and practical timeline

This NOFO has structured cycles. Key date windows include:

• Open/earliest application date: 28 September 2025
• 2026 full due date: 06 October 2026 (5:00 PM local time of applicant)
• 2027 full due date: 06 October 2027
• 2028 full due date: 06 October 2028
• Expires: 09 November 2027

For most applicants in 2026, the practical sequence is:

• Build scope and team by early September.
• Draft technical sections in parallel with data-sharing and resource-sharing plans.
• Complete registrations and PI profiles early.
• Submit early in October 2026 to absorb system correction cycles.

Review/award rhythm on the 2026 cycle is also published: peer review in November/early spring and council in May with July starts. This matters because a strong but late submission may still miss internal institutional quality-control windows.

A useful rule: submitting before the listed deadline is not just “nice to have”; for NIH systems with large form-based validation, extra time avoids avoidable failed transmission events.

Funding level, budget logic, and support duration

The NOFO states:

• NIH anticipates up to 15 awards per year from a $6M annual pool.
• Project budgets are not capped, but expected to range from $150,000 to $350,000 direct costs/year.
• Project period is 3 years.

Because direct budgets are not strictly capped, high-quality proposals usually optimize on rationale instead of claiming an inflated budget. Reviewers and post-submission screening often reward budget realism:

• Tie each cost to a milestone.
• Connect personnel effort to clear deliverables.
• Include travel budget only if it directly contributes to required conference interaction, collaboration, or BRAIN meeting participation that advances deliverables.

You can treat this as a “build once, share broadly” model:

• Year 1: model and tool design + pilot validation.
• Year 2: full validation, community integration, endpoint metrics.
• Year 3: dissemination, archive/submissions cadence, final hardening.

This cadence also matches NIH’s expectations around data sharing and community usability, especially because this NOFO is explicitly community-facing.

Why this may fit your team

This NOFO is strongest for teams that can prove two things at once:

1. Methodological novelty that moves the field forward.
2. Implementation practicality through collaboration between theorists, modelers, data scientists, and end users.

Projects that are strong for review typically show:

• A clearly defined deliverable, not just broad intent.
• A rigorous path from hypothesis to model to validation.
• Explicit community adoption strategy for broader use.
• A direct plan for sharing not only raw results but tools, code, pipelines, or interfaces.

If your team is mostly experimental with limited modeling capacity, consider adding a co-investigator with the required formal modeling depth. If your team is theory-heavy with less data infrastructure, bring in data and systems collaborators early.

Application process and submission mechanics

The NOFO allows standard NIH submission routes:

• ASSIST
• institutional system-to-system solution
• Grants.gov Workspace

Paper submissions are not accepted.

Submission-specific must-haves:

• Use the required application package for this NOFO.
• Respect all NIH Research (R) Instructions and NIH How to Apply guide conventions.
• Ensure full compliance with page limits and required forms.
• Include both:
  • Resource sharing plan (covering algorithms/models/methods/software/protocols/software dissemination)
  • Data Management and Sharing Plan (NIH policy applies broadly)

Data sharing is not optional in the spirit of this NOFO. The source says BRAIN initiatives require coordinated archival strategy and 6-monthly submission cadence into approved BRAIN archives.

For teams with potential human subjects or vertebrate animals components, include all required protections and reporting sections. For most methods-focused projects, this may be light, but if your dataset or pipeline includes human-derived elements, the documentation burden increases.

How NIH reviews these applications

The NOFO provides review criteria that matter in practice:

What reviewers score

• Factor 1: Importance, significance, innovation

  • Is there a clear rationale?
  • Is the gap well identified?
  • Are deliverables clearly valuable and broadly useful?

• Factor 2: Rigor and feasibility

  • Is the study design strong and reproducible?
  • Is sample/statistical handling explained?
  • Are assumptions explicit?

• Factor 3: Investigator(s) and environment

  • Is the team sufficient?
  • Do collaborators cover model/data/tool translation?

Additional criteria include human subjects protections, vertebrate animal sections, biohazards where applicable, and budget supportability.

BRAIN-specific review emphasis

The NOFO gives specific reviewer cues that are important for fit:

• Are outputs clearly defined and reusable by the field?
• Are tools useful at a community level, not just within your lab?
• Are multi-scale integration and measurable confidence strategies explicit?

It is therefore easier to pass review when the proposal demonstrates end-user collaboration and adoption paths, not only model elegance.

Critical preparation strategy for a stronger submission

A practical sequence that works:

Phase 1: Scope and fit (4–6 weeks)

• Confirm your project is not a clinical trial.
• Ensure data source compatibility includes cell-type/circuit-level or appropriate integration approach.
• Define outputs as shareable modules/tools, not internal code only.
• Draft a one-page impact framing paragraph in language reviewers can score.

Phase 2: Compliance and partner architecture (3–4 weeks)

• Lock registrations (SAM, UEI, eRA Commons, Grants.gov).
• Define subaward roles and remove disallowed monetary foreign subcontracts.
• Confirm all institutions can support 3-year administration.
• Assign PI and co-PI roles and ensure eRA profiles are complete.

Phase 3: Methods and validation narrative (3–5 weeks)

• Create metrics for validation and uncertainty handling.
• Align methods with biological variables and reproducibility requirements.
• Include failure-mode analysis: what if model fails on edge conditions?
• Add explicit computational reproducibility and sharing details.

Phase 4: Policy and review packaging (2–3 weeks)

• Add full resource-sharing section.
• Add Data Management and Sharing Plan with archive strategy and schedule.
• Ensure budget matches milestones and is in the expected NIH range.
• Run a compliance check for every required SF424 section before final validation.

Phase 5: Pre-submission resilience (final days)

• Review application in eRA Commons for on-time submission confirmation.
• Leave buffer time for technical corrections; NIH explicitly expects corrected applications before the deadline.
• Submit early enough to recover from eRA/Grants.gov propagation issues.

Common mistakes to avoid

1. Ignoring the non-response checklist. If your method does not leverage high-resolution data integration where required, it can be screened out.
2. Treating data sharing as optional copy in a separate appendix. It is central to this NOFO.
3. Submitting duplicate applications that overlap too closely. NIH blocks overlapping/new or resubmission families before review.
4. Underspecifying foreign involvement in relation to the post-2025 foreign-subaward policy.
5. Missing required registrations and role setup in institutional systems.
6. Overpromising milestones with unsupported compute or staffing budgets.
7. Submitting late without accounting for post-submission error correction windows.

Common questions

Is this still relevant for 2026/2027?

Yes. The NOFO includes 2026 and 2027 application cycles with specific due dates and review timing. It is published with future due dates and is active for this cycle.

Is this only for clinical trial applicants?

No. In this NOFO, NIH clearly states clinical trials are not accepted.

Can foreign universities or teams apply?

Foreign entities are on the eligibility roster, but funded foreign subawards/subcontracts are restricted under current NIH policy. Plan cross-border collaboration carefully.

Is there a fixed grant cap?

The NOFO does not set a hard cap per award but provides expected annual direct budget expectations of $150k–$350k. Use this as the planning band.

Are there fixed funding rounds?

The funding is pooled and contingent on merit and appropriations. The text says up to 15 awards per year from a $6M annual pool, not guaranteed awards for every applicant.

What is a strong differentiator in review?

Community impact and measurable reusability. Explicit evidence that your tools are likely to be adopted beyond your lab carries strong weight.

Official links and next action

• https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-27-004.html
• https://grants.nih.gov/grants/how-to-apply-application-guide
• https://www.nih.gov

If you are planning a submission this year, the highest-return action is to complete registration, freeze your team map (including foreign partner roles), and start the draft resource-sharing and data-plan sections before full prose. This NOFO rewards technical discipline and compliance as much as scientific novelty.